Risks Faced by Becton, Dickinson and Company

As it is susceptible to industry risks, Becton, Dickinson and Company (BDX), or BD, is transforming its business model.

Sarah Collins - Author

Dec. 16 2015, Updated 10:05 a.m. ET


Key risks

The medical device industry in the United States is a highly competitive industry. It presents a number of risks, such as pricing pressures, reimbursement risks, healthcare consolidation, and tax burdens. As it is susceptible to these industry risks, Becton, Dickinson and Company (BDX), or BD, is transforming its business model. In addition to industry risks, BD faces company-specific risks, such as raw material price fluctuations, foreign currency risks, and integration risks.

Article continues below advertisement
Article continues below advertisement

Integration risk

BD acquired CareFusion on March 17, 2015, in a cash-and-stock deal. CareFusion has a broad portfolio of products and extensive geographic reach. BD faces the massive challenge of integrating two medical device companies. Though the company has achieved substantial synergies as of fiscal 4Q15, and is expected to achieve even higher cost synergies by 2018, significant integration risks still exist.

Raw material price fluctuations

Resins, which are oil-based, are a major component used in the manufacturing of medical devices. Resin purchase costs are significantly impacted by increasing world oil prices, which could affect future operating results. The company employs various measures, such as purchasing commodity derivative contracts, to manage these risks. In April 2015, in order to hedge approximately 13% of its global resin purchase volumes in 2015 and 2016, BD entered into cash-settled forward contracts.

Foreign currency risk

More than 50% of BD’s total revenues are derived from international operations. Fluctuation in currency exchange rates affects the company’s revenues significantly. Also, a potential decrease in demand due to the strong dollar poses a significant risk to the company’s business.

Medtronic (MDT), Stryker (SYK), and Johnson & Johnson (JNJ) are some of the other big players in the medical device industry. They are also susceptible to integration risk due to a large number of mergers and acquisition deals. Investors seeking diversified exposure to BD can invest in the First Trust Health Care AlphaDEX ETF (FXH). The company accounts for around 1.5% of FXH’s total holdings.


Latest Becton, Dickinson And Co. News and Updates

    Opt-out of personalized ads

    © Copyright 2024 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.